Plazomicin Nitroso Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Plazomicin is a parenterally administered, broad spectrum aminoglycoside antibiotic typically used for moderate-to-severe urinary tract infections or pyelonephritis.Plazomicin Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Plazomicin Nitroso Impurity 1 CAS NO:NA Chemically represented as (S)-4-amino-N-((1R,2S,3S,4R,5S)-5-amino-4-(((2S,3R)-3-amino-6-(((2-hydroxyethyl)amino)methyl)-3,4-dihydro-2H-pyran-2-yl)oxy)-2-(((2R,3R,4R,5R)-3,5-dihydroxy-5-methyl-4-(methyl(nitroso)amino)tetrahydro-2H-pyran-2-yl)oxy)-3-hydroxycyclohexyl)-2-hydroxybutanamide. Synchemia is the leading manufacturing and exporter of Plazomicin Nitroso Impurity 1. We supply Plazomicin Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0142019 |
| CAS No | NA |
| Mol.F. | C19H18N2O |
| Mol.Wt. | 290.37 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142020 |
| CAS No | NA |
| Mol.F. | C21H22N2O3 |
| Mol.Wt. | 350.42 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142021 |
| CAS No | NA |
| Mol.F. | C26H34N2O9 |
| Mol.Wt. | 518.56 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142022 |
| CAS No | NA |
| Mol.F. | C17H25IN2O5 |
| Mol.Wt. | 464.3 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142023 |
| CAS No | NA |
| Mol.F. | C17H22N2O3 |
| Mol.Wt. | 302.37 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142024 |
| CAS No | NA |
| Mol.F. | C17H26N2O3 |
| Mol.Wt. | 306.41 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142025 |
| CAS No | NA |
| Mol.F. | C10H12N6O5 |
| Mol.Wt. | 296.24 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142026 |
| CAS No | NA |
| Mol.F. | C19H18FN7O6 |
| Mol.Wt. | 459.39 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142027 |
| CAS No | NA |
| Mol.F. | C22H28N2O4 |
| Mol.Wt. | 384.14 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142028 |
| CAS No | NA |
| Mol.F. | C10H12N2O |
| Mol.Wt. | 176.2 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142029 |
| CAS No | NA |
| Mol.F. | C12H12N2O |
| Mol.Wt. | 200.1 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142030 |
| CAS No | NA |
| Mol.F. | C31H48N2O12 |
| Mol.Wt. | 640.7 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142031 |
| CAS No | NA |
| Mol.F. | C20H22N2O5 |
| Mol.Wt. | 370.41 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142032 |
| CAS No | NA |
| Mol.F. | C16H16N2O6 |
| Mol.Wt. | 332.31 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142033 |
| CAS No | NA |
| Mol.F. | C21H20N2O8 |
| Mol.Wt. | 428.4 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142034 |
| CAS No | NA |
| Mol.F. | C17H10N2O8 |
| Mol.Wt. | 370.3 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |